Thema: ScienceDaily
Surgery doesn’t always help with chronic rhinosinusitis — a new risk score predicts treatment...
A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis.
Researchers find intestinal immune cell prevents food allergies
Researchers found that a small population of immune cells in the mouse intestine prevents allergic responses to food, suggesting that targeting such cells therapeutically...
Understanding the immune response to a persistent pathogen
Researchers show that the immune system can recognize and control the latent stage of the parasite Toxoplasma gondii, a finding that can inform the study of latency in other infections of the nervous system.
New treatment option for psoriasis discovered
Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on inhibiting pro-inflammatory immune cells, a study shows that it is possible to restore the function of certain anti-inflammatory immune cells in a targeted manner. The results pave the way for the development of a therapy that not only works more precisely but is also associated with fewer side effects.
Bottling a mouse ’superpower‘ may heal lungs damaged by premature birth
Using a four-dimensional microscopy technique, researchers have created 3D video images of mouse lung tissue grown in the laboratory. What they have learned has been nothing short of groundbreaking.
Stopping asthma in its tracks
New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.
Eating gradually increasing doses of peanut butter enables children with high-threshold allergy to safely...
Findings suggest a safe, inexpensive, and effective pathway for allergists to treat children who already tolerate at least half a peanut.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik:...
Nasal spray shows preclinical promise for treating traumatic brain injury
A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the nasal anti-CD3 in a mouse model of TBI, researchers found the spray could reduce damage to the central nervous system and behavioral deficits, suggesting a potential therapeutic approach for TBI and other acute forms of brain injury.
A light-activated drug to fight psoriasis
Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated by an altered immune system response that triggers the proliferation of skin cells. Depending on the severity, there are different therapeutic options (topical medications, phototherapy, systemic drugs, etc.), but some conventional treatments can have harmful effects on patients.
Asthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery
The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was not a predictor of revision surgery, according to a new study.
- Äußere Behandlung bei Schuppenflechte
- Neurodermitis – Eintrittspforte für weitere Allergien
- Glutenfrei Reisen – Gute Planung ist alles
- Leben mit Erdnussallergie – Wichtige Fakten auf einen Blick
- What If You’re Allergic to Grass? 10 Steps to Managing Grass Pollen Allergy
- Location matters: Belly fat compared to overall body fat more strongly linked to psoriasis risk
- Verbändeappell für Nichtraucherschutz in Fußballstadien
- Blasen an den Füßen vorbeugen und behandeln
- Possible complications of psoriasis
- Unusual carbon build-up found in lungs of COPD patients